» Articles » PMID: 23596312

Bruton's Tyrosine Kinase is Required for Apoptotic Cell Uptake Via Regulating the Phosphorylation and Localization of Calreticulin

Overview
Journal J Immunol
Date 2013 Apr 19
PMID 23596312
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

In addition to regulating B cell development and activation, Bruton's tyrosine kinase (Btk) functions downstream of multiple TLRs, including TLR7, to regulate innate immune responses in myeloid cells. Although critical for defense against RNA viruses such as influenza and Sendai virus, recognition of self-RNA by TLR7 also has been shown to be an important contributor to the pathophysiology of systemic lupus erythematosus. To date, the role of Btk in regulating TLR7-mediated responses is poorly understood. In the current study, we have demonstrated a hitherto undiscovered role for Btk in apoptotic cell uptake, identifying the molecular chaperone calreticulin (CRT) as a novel substrate for Btk in regulating this response. CRT together with the transmembrane receptor CD91 function at the cell membrane and regulate uptake of C1q-opsonised apoptotic cells. Our results show that Btk directly phosphorylates CRT and that in the absence of Btk, CRT fails to localize with CD91 at the cell surface and at the phagocytic cup. Critically, a blocking Ab against CRT in wild-type macrophages mimics the inability of Btk-deficient macrophages to phagocytose apoptotic cells efficiently, indicating the critical importance of Btk in regulating CRT-driven apoptotic cell uptake. Our data have revealed a novel regulatory role for Btk in mediating apoptotic cell clearance, with CRT identified as the critical component of the CRT/CD91/C1q system targeted by Btk. Given the importance of clearing apoptotic cell debris to prevent inappropriate exposure of TLRs to endogenous ligands, our results have important implications regarding the role of Btk in myeloid cell function.

Citing Articles

The Integrated Bioinformatic Approach Reveals the Prognostic Significance of LRP1 Expression in Ovarian Cancer.

Wolde T, Bhardwaj V, Reyad-Ul-Ferdous M, Qin P, Pandey V Int J Mol Sci. 2024; 25(14).

PMID: 39063239 PMC: 11276689. DOI: 10.3390/ijms25147996.


"Find Me" and "Eat Me" signals: tools to drive phagocytic processes for modulating antitumor immunity.

Xiao L, Zhang L, Guo C, Xin Q, Gu X, Jiang C Cancer Commun (Lond). 2024; 44(7):791-832.

PMID: 38923737 PMC: 11260773. DOI: 10.1002/cac2.12579.


Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy.

Toledo B, Zhu Chen L, Paniagua-Sancho M, Marchal J, Peran M, Giovannetti E J Hematol Oncol. 2024; 17(1):44.

PMID: 38863020 PMC: 11167803. DOI: 10.1186/s13045-024-01559-0.


A Review on Role of Inflammation in Coronavirus Disease.

Lotfi A, Hajian P, Abbasi L, Gargari M, Fard N, Naderi D Endocr Metab Immune Disord Drug Targets. 2024; 24(13):1488-1505.

PMID: 38303532 DOI: 10.2174/0118715303265274231204075802.


Don't eat me/eat me signals as a novel strategy in cancer immunotherapy.

Khalaji A, Baharlouei Yancheshmeh F, Farham F, Khorram A, Sheshbolouki S, Zokaei M Heliyon. 2023; 9(10):e20507.

PMID: 37822610 PMC: 10562801. DOI: 10.1016/j.heliyon.2023.e20507.